Chitogen
Chitogen, a Minneapolis-based medical device company, specializes in manufacturing and selling topical hemostats and wound care products.
Founded
2007Chitogen, a Minneapolis-based medical device company, specializes in manufacturing and selling topical hemostats and wound care products.
Chitogen, founded in 2007 and based in Minneapolis, Minnesota, is a medical device company dedicated to designing, manufacturing, and selling topical hemostats and wound care products. The company's mission is to provide innovative solutions for rapid hemostasis and improved patient comfort. Chitogen's product line includes the SoftSeal®-STF, SoftSeal®-STFR, D-Seal®, and TRAUMASTAT™, all of which leverage chitosan technology to accelerate blood clotting and reduce compression time.
Chitogen's core team comprises experienced professionals from the medical device startup and wound care sectors. The company has successfully commercialized its initial products, gaining recognition for its advanced hemostatic solutions. Notable investors and affiliations include key figures in the medical device industry, contributing to Chitogen's credibility and growth. The impact of Chitogen's products is evident in their widespread adoption for safe and quick bleeding control, enhancing patient outcomes in various medical settings.
Companies similar to Chitogen include Axio Biosolutions, Protege Biomedical, Cresilon and KitoTech Medical.
Chitogen was founded in 2007.
Chitogen's headquarters is located in Plymouth, MN, US.
Chitogen's most recent funding round was for $523.5k (USD) in October 2018.
As of Oct 9, 2018, Chitogen has disclosed funding of $2.3M (USD). Undisclosed round amounts are excluded.
Chitogen has 30 employees as of Feb 5, 2024.
KitoTech Medical
